Evidence of safety for pretomanid and male reproductive health

Int J Tuberc Lung Dis. 2022 Jun 1;26(6):473-474. doi: 10.5588/ijtld.22.0092.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Humans
  • Male
  • Nitroimidazoles*
  • Reproductive Health*

Substances

  • Antitubercular Agents
  • Nitroimidazoles
  • pretomanid